Global Blood Therapeutics announces pricing of public offering of 4,000,000 shares
Global Blood Therapeutics announced pricing of an underwritten public offering of 4,000,000 shares of its common stock at a price to the public of $54.00 per share. Gross proceeds are expected to be $216.0 million. GBT granted underwriters a 30-day option to purchase up to 600,000 shares. March 08, 2018